Date
21 January 2026

Time
 10:00-11:00 EST | 15:00-16:00 GMT | 16:00-17:00 CET

Key features
This presentation is intended for professionals involved in biopharmaceutical manufacturing, facility design, and strategic operations. It will be particularly relevant to:

• Process development scientists and manufacturing engineers exploring flexible facility models to support diverse therapeutic modalities.
• Regulatory affairs and quality assurance specialists assessing compliance implications of multi-modal environments.
• Facility planners and operations leaders evaluating single-use technologies and adaptive layouts.
• CDMO executives and biopharma strategists seeking scalable, cost-effective solutions for pipeline variability.
• Corporate decision-makers responsible for capital investment, sustainability, and innovation in manufacturing infrastructure.

Attendees will benefit from practical frameworks, case studies, and strategic insights to guide decision-making around multi-modal manufacturing adoption.

Why attend?

• Attendees will benefit from understanding  practical frameworks
• Hear real world case studies
• Gain strategic insights to guide decision-making around multi-modal manufacturing adoption